Personalized Approach to Primary and Secondary Prevention of Ischemic Stroke

Overview

Journal EPMA J

Date 2014 Jun 21

PMID 24949113

Citations 5

Authors

Jiri Polivka

Vladimir Rohan

Petr Sevcik

Jiri Polivka Jr

Affiliations

Soon will be listed here.

Abstract

Primary and secondary prevention of ischemic stroke represents a significant part of stroke management and health care. Although there are official guidelines concerning stroke management, new knowledge are introduced to them with a slight delay. This article provides an overview of current information on primary and secondary prevention of ischemic stroke. It summarizes information especially in the field of cardioembolic stroke, the use of new anticoagulants and the management of carotid stenosis based on the results of recent clinical studies. The optimal approach in stroke management is to follow these recommendations, to know new strategies and to apply an individual personalized approach in our clinical decisions.

Citing Articles

Risks associated with the stroke predisposition at young age: facts and hypotheses in light of individualized predictive and preventive approach.

Polivka Jr J, Polivka J, Pesta M, Rohan V, Celedova L, Mahajani S EPMA J. 2019; 10(1):81-99.

PMID: 30984317 PMC: 6459458. DOI: 10.1007/s13167-019-00162-5.

Predictive and individualized management of stroke-success story in Czech Republic.

Polivka J, Polivka Jr J, Rohan V EPMA J. 2018; 9(4):393-401.

PMID: 30538791 PMC: 6261911. DOI: 10.1007/s13167-018-0150-x.

Distribution of Stroke Risk Factors in Eastern Croatia.

Rostohar Bijelic B, Petek M, Kadojic M, Bijelic N, Kadojic D Acta Clin Croat. 2018; 57(1):103-109.

PMID: 30256017 PMC: 6400360. DOI: 10.20471/acc.2018.57.01.12.

Pre-graduate and post-graduate education in personalized medicine in the Czech Republic: statistics, analysis and recommendations.

Polivka Jr J, Polivka J, Karlikova M, Topolcan O EPMA J. 2015; 5(1):22.

PMID: 25904992 PMC: 4406177. DOI: 10.1186/1878-5085-5-22.

Strokes in young adults: epidemiology and prevention.

Smajlovic D Vasc Health Risk Manag. 2015; 11:157-64.

PMID: 25750539 PMC: 4348138. DOI: 10.2147/VHRM.S53203.

References

Friberg L, Rosenqvist M, Lip G . Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur Heart J. 2012; 33(12):1500-10. DOI: 10.1093/eurheartj/ehr488. View

Bhatt D, Fox K, Hacke W, Berger P, Black H, Boden W . Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006; 354(16):1706-17. DOI: 10.1056/NEJMoa060989. View

Sandercock P, Counsell C, Kamal A . Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev. 2008; (4):CD000024. DOI: 10.1002/14651858.CD000024.pub3. View

Pisters R, Lane D, Nieuwlaat R, de Vos C, Crijns H, Lip G . A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010; 138(5):1093-100. DOI: 10.1378/chest.10-0134. View

Conroy R, Pyorala K, Fitzgerald A, Sans S, Menotti A, De Backer G . Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003; 24(11):987-1003. DOI: 10.1016/s0195-668x(03)00114-3. View

Halliday A, Harrison M, Hayter E, Kong X, Mansfield A, Marro J . 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet. 2010; 376(9746):1074-84. PMC: 2956884. DOI: 10.1016/S0140-6736(10)61197-X. View

Giugliano R, Ruff C, Braunwald E, Murphy S, Wiviott S, Halperin J . Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013; 369(22):2093-104. DOI: 10.1056/NEJMoa1310907. View

Benavente O, Hart R, McClure L, Szychowski J, Coffey C, Pearce L . Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med. 2012; 367(9):817-25. PMC: 4067036. DOI: 10.1056/NEJMoa1204133. View

Siegal D, Cuker A . Reversal of novel oral anticoagulants in patients with major bleeding. J Thromb Thrombolysis. 2013; 35(3):391-8. DOI: 10.1007/s11239-013-0885-0. View

10.

Rizos T, Guntner J, Jenetzky E, Marquardt L, Reichardt C, Becker R . Continuous stroke unit electrocardiographic monitoring versus 24-hour Holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke. Stroke. 2012; 43(10):2689-94. DOI: 10.1161/STROKEAHA.112.654954. View

11.

Huisman M, Lip G, Diener H, Brueckmann M, van Ryn J, Clemens A . Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: resolving uncertainties in routine practice. Thromb Haemost. 2012; 107(5):838-47. DOI: 10.1160/TH11-10-0718. View

12.

Mantha S, Ansell J . An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation. Thromb Haemost. 2012; 108(3):476-84. DOI: 10.1160/TH12-02-0093. View

13.

Golubnitschaja O, Costigliola V . General report & recommendations in predictive, preventive and personalised medicine 2012: white paper of the European Association for Predictive, Preventive and Personalised Medicine. EPMA J. 2012; 3(1):14. PMC: 3485619. DOI: 10.1186/1878-5085-3-14. View

14.

Olesen J, Lip G, Lindhardsen J, Lane D, Ahlehoff O, Hansen M . Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a 'real world' nationwide cohort study. Thromb Haemost. 2011; 106(4):739-49. DOI: 10.1160/TH11-05-0364. View

15.

Catapano A, Reiner Z, De Backer G, Graham I, Taskinen M, Wiklund O . ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis. 2011; 217(1):3-46. DOI: 10.1016/j.atherosclerosis.2011.06.028. View

16.

Feigin V, Lawes C, Bennett D, Barker-Collo S, Parag V . Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009; 8(4):355-69. DOI: 10.1016/S1474-4422(09)70025-0. View

17.

Martinez-Garcia M, Campos-Rodriguez F, Soler-Cataluna J, Catalan-Serra P, Roman-Sanchez P, Montserrat J . Increased incidence of nonfatal cardiovascular events in stroke patients with sleep apnoea: effect of CPAP treatment. Eur Respir J. 2011; 39(4):906-12. DOI: 10.1183/09031936.00011311. View

18.

Huang Y, Cai X, Li Y, Su L, Mai W, Wang S . Prehypertension and the risk of stroke: a meta-analysis. Neurology. 2014; 82(13):1153-61. DOI: 10.1212/WNL.0000000000000268. View

19.

. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008; 25(5):457-507. DOI: 10.1159/000131083. View

20.

Amarenco P, Labreuche J . Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol. 2009; 8(5):453-63. DOI: 10.1016/S1474-4422(09)70058-4. View